Cargando…

Risk Factors for Indeterminate Outcome on Interferon Gamma Release Assay in Non-US-Born Persons Screened for Latent Tuberculosis Infection

BACKGROUND: Non-US-born individuals account for the majority of active tuberculosis (TB) in the United States. Interferon gamma release assay (IGRA) is the preferred diagnostic test for latent TB but can produce an indeterminate result. We investigated the prevalence and predictors of an indetermina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharninghausen, Jody C, Shapiro, Adrienne E, Koelle, David M, Kim, H Nina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104778/ https://www.ncbi.nlm.nih.gov/pubmed/30151410 http://dx.doi.org/10.1093/ofid/ofy184

Ejemplares similares

Indeterminate results of interferon gamma release assays in the screening of latent tuberculosis infection: a systematic review and meta-analysis
por: Zhou, Guozhong, et al.
Publicado: (2023)

Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis
por: Doan, Tan N., et al.
Publicado: (2017)

Risk Stratification of Latent Tuberculosis Defined by Combined Interferon Gamma Release Assays
por: Corbière, Véronique, et al.
Publicado: (2012)

Estimated Prevalence of Tuberculosis Infection Among a New York City Clinic Population Using Interferon-gamma Release Assays
por: Stennis, Natalie L., et al.
Publicado: (2014)

In-hospital blood collection increases the rate of indeterminate results in interferon-gamma release assays
por: Osakabe, Yuki, et al.
Publicado: (2022)

Interferon gamma release assays for detection of latent Mycobacterium tuberculosis in older Hispanic people
por: Scordo, Julia M., et al.
Publicado: (2021)

Risk Factors for Indeterminate Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis in Children—A Systematic Review and Meta-Analysis
por: Meier, Noëmi R., et al.
Publicado: (2019)

Latent Tuberculosis Screening Cascade for Non–US-Born Persons in a Large Health System
por: Shapiro, Adrienne E, et al.
Publicado: (2023)

Frequency of indeterminate results from an interferon-gamma release assay among HIV-infected individuals
por: de Oliveira, Sandra Maria do Valle Leone, et al.
Publicado: (2017)

Validation and Clinical Application of Interferon-Gamma Release Assay for Diagnosis of Latent Tuberculosis Infection in Children
por: Benachinmardi, Kirtilaxmi K, et al.
Publicado: (2019)

The Usefulness of the Tuberculosis Skin Test and the Interferon-gamma Release Assay in the Diagnosis of Latent Tuberculosis Infection in South Korea
por: Jang, Ju Young, et al.
Publicado: (2014)

622. Development of Interferon-Gamma Release Assays for Diagnosing Latent Talaromycosis
por: Xu, Helen, et al.
Publicado: (2023)

Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays
por: Blount, Robert J., et al.
Publicado: (2016)

Serial Interferon-gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in Patients Treated with Immunosuppressive Agents
por: Kim, Kyeong-Hee, et al.
Publicado: (2011)

Diagnosis of latent tuberculosis infection among HIV discordant partners using interferon gamma release assays
por: Talati, Naasha J, et al.
Publicado: (2011)

Tuberculin Skin Testing and Treatment Modulates Interferon-Gamma Release Assay Results for Latent Tuberculosis in Migrants
por: O'Shea, Matthew K., et al.
Publicado: (2014)

Chest roentgenography is complementary to interferon-gamma release assay in latent tuberculosis infection screening of rheumatic patients
por: Wang, Ping-Huai, et al.
Publicado: (2020)

Predictors for False-Negative Interferon-Gamma Release Assay Results in Hemodialysis Patients with Latent Tuberculosis Infection
por: Park, Heechul, et al.
Publicado: (2022)

Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence
por: Trajman, A., et al.
Publicado: (2013)

Comparison of interferon gamma release assay & tuberculin skin tests for diagnosis of latent tuberculosis in patients on maintenance haemodialysis
por: Agarwal, Sanjay K., et al.
Publicado: (2015)

Circulating granulysin levels in healthcare workers and latent tuberculosis infection estimated using interferon-gamma release assays
por: Thuong, Pham Huu, et al.
Publicado: (2016)

Evaluation of role of interferon gamma release assays in the diagnosis of latent tuberculosis in human immunodeficiency virus-infected patients
por: Singh, Rajender, et al.
Publicado: (2021)

Utility of the Interferon-Gamma Release Assay for Latent Tuberculosis Infection Screening among Indian Health-Care Workers
por: Girish, Sunita, et al.
Publicado: (2021)

Evaluation of a New Chemiluminescent Immunoassay-Based Interferon-Gamma Release Assay for Detection of Latent Tuberculosis Infection
por: Kim, Keun Ju, et al.
Publicado: (2023)

The Use of Interferon Gamma Release Assays in the Diagnosis of Active Tuberculosis
por: Vesenbeckh, Silvan M., et al.
Publicado: (2012)

Interferon-Gamma Release Assay Performance in Pulmonary and Extrapulmonary Tuberculosis
por: Feng, Yun, et al.
Publicado: (2012)

Basic and clinical immunology- 3019. Gamma interferon release assay for diagnosis of latent tuberculosis – comparison with TB skin test
por: Kumar, Prem, et al.
Publicado: (2013)

1476 Screening for Latent Tuberculosis Infection in Internationally Adopted Children in the era of Interferon-Gamma Release Assay (IGRA) Testing
por: Dhar, Cherie Priya, et al.
Publicado: (2014)

Concordance between tuberculin skin test and interferon-gamma release assay for latent tuberculosis screening in inflammatory bowel disease
por: Alrajhi, Saad, et al.
Publicado: (2020)

Is the New Interferon-Gamma Releasing Assay Beneficial for the Diagnosis of Latent and Active Mycobacterium tuberculosis Infections in Tertiary Care Setting?
por: Jung, Jaewan, et al.
Publicado: (2021)

Fewer losses in the cascade of care for latent tuberculosis with solo interferon-gamma release assay screening compared to sequential screening
por: Lim, R. K., et al.
Publicado: (2021)

Interferon-gamma release assay versus tuberculin skin test for latent tuberculosis infection among HIV patients in Brazil
por: Kussen, Gislene Maria Botão, et al.
Publicado: (2015)

Assessing the Diagnostic Performance of New Commercial Interferon-γ Release Assays for Mycobacterium tuberculosis Infection: A Systematic Review and Meta-Analysis
por: Ortiz-Brizuela, Edgar, et al.
Publicado: (2023)

Estimating Latent Tuberculosis Infection Using Interferon-γ Release Assay, Japan
por: Nishimura, Tomoyasu, et al.
Publicado: (2018)

Population tailored modification of tuberculosis specific interferon-gamma release assay
por: Horvati, Kata, et al.
Publicado: (2016)

Interferon-Gamma Release Assay in a Patient with Tuberculosis Verrucosa Cutis
por: Kim, Geon, et al.
Publicado: (2015)

Diagnostic Value of Interferon-Gamma Release Assays for Tuberculosis in the Immunocompromised Population
por: Yang, Ying, et al.
Publicado: (2022)

Serial interferon-gamma release assays for latent tuberculosis in dialysis patients with end stage renal disease in a Korean population
por: Lee, Seung Heon, et al.
Publicado: (2015)

Factors associated with non-initiation of latent tuberculosis treatment among healthcare workers with a positive interferon-gamma releasing assay
por: Lee, Hyun, et al.
Publicado: (2019)

1377. Use of Interferon-Gamma Release Assays (IGRAs) Reduced Latent Tuberculosis Infection (LTBI) Diagnosis in Refugee and Immigrant Children
por: Kushner, Lauren E, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_blh5gnkcnrid9ma2cbbgdjipuo